United States· US:70954-212_83608c13-509d-448b-8559-5f5e8a9a0d75
TRIHEXYPHENIDYL HYDROCHLORIDE
A trihexyphenidyl product containing trihexyphenidyl hydrochloride, registered in United States by Novitium Pharma LLC. The same ATC class is registered in 10 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Trihexyphenidyl is registered in 10 of 19 countries.
Countries holding a registration under ATC N04AA01 (trihexyphenidyl), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 5 of them publish a price we can compare per daily dose
Trihexyphenidyl · ATC N04AA01
10 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Franceprice
- Germany
- Japan
- Netherlands
- Norwayprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of trihexyphenidyl costs, country by country.
Normalised to the WHO defined daily dose (10 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Trihexyphenidyl · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- FR France$0.20
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- TRIHEXYPHENIDYL HYDROCHLORIDE
- Manufacturer
- Novitium Pharma LLC
- Country
- United States (US)
- ATC code
- N04AA01
- ATC class
- Trihexyphenidyl
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc117095421210100 TABLET in 1 BOTTLE (70954-212-10)
- ndc1170954212201000 TABLET in 1 BOTTLE (70954-212-20)
- ndc1170954-212-10
- ndc1170954-212-20
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
141 interactions on record for trihexyphenidyl.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Trihexyphenidyl · interactions on record
141 records
- 3 severe
- 89 moderate
- 1 minor
- 48 info
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium chlorideB05XA01severe
- Magnesium hydroxideA02AA04moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Trihexyphenidyl in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAgitane 2mg tabletsDr Reddy's Laboratories (UK) Ltd
- FranceARTANE 2 mg, compriméNEURAXPHARM FRANCE
- NorwayArtaneTeofarma
- FinlandArtaneWyeth Lederle Nordiska Ab
- SpainARTANE 2 MG COMPRIMIDOSTeofarma S.R.L.
- CanadaTRIHEXYPHENIDYLAA PHARMA INC
- BelgiumArtane 2 mgTeofarma
- GermanyArtaneTeofarma S.R.L.
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Belgium · Artane
- Cyprus · Benzhexol
- Germany · Artane, Parkopan
- Estonia · Cyclodol
- Spain · Artane
- France · Artane, Parkinane Lp
- United Kingdom (Northern Ireland) · Agitane, Benzhexol
- Italy · Artane
- Lithuania · Cyclodol, Parkopan
- Luxembourg · Artane
- Latvia · Cyclodol
- Malta · Benzhexol, Trihexyphenidyl
- Netherlands · Artane
- Portugal · Artane
- Romania · Romparkin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cd60b350-92ae-4dc2-9350-e4f83cce420e GET /v1/drugs/cd60b350-92ae-4dc2-9350-e4f83cce420e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "2",
"substance": "TRIHEXYPHENIDYL HYDROCHLORIDE",
"productndc": "70954-212",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA040254",
"marketing_category": "ANDA"
}See everything about trihexyphenidyl.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.